Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 3,669 |
|
|||||
| News | - | ||||||
| Day High | 2.4465 | Low High |
|||||
| Day Low | 2.33 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| CASI Pharmaceuticals Inc | CASI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.08 | 3.48% | 2.38 | 23:00:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.33 | 2.33 | 2.4465 | 2.42 | 2.30 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 69 | 3,669 | US$ 2.42 | US$ 8,891 | - | 1.85 - 8.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:43:03 | 10 | US$ 2.3481 | USD |
CASI Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.37M | 13.32M | - | 43.11M | -41.01M | -3.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CASI Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/08/2024 | 16:00 | PR Newswire (US) | CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS.. |
| 3/28/2024 | 06:00 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR.. |
| 3/05/2024 | 06:00 | PR Newswire (US) | CASI Pharmaceuticals Report Positive Interim Phase 1 Data.. |
| 2/16/2024 | 06:00 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN.. |
| 11/14/2023 | 06:00 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS.. |
| 11/08/2023 | 06:00 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY.. |
| 8/11/2023 | 06:00 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS.. |
| 8/01/2023 | 06:00 | PR Newswire (US) | Mundipharma International Corporation Limited, Mundipharma.. |
| 7/20/2023 | 07:00 | PR Newswire (US) | CASI Pharmaceuticals Acquires Global Intellectual Property.. |
| 5/17/2023 | 06:35 | PR Newswire (US) | CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CASI Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.18 | 2.61 | 2.18 | 2.37 | 14,364 | 0.20 | 9.17% |
| 1 Month | 3.69 | 3.69 | 2.05 | 2.88 | 42,087 | -1.31 | -35.50% |
| 3 Months | 6.44 | 6.86 | 2.05 | 5.26 | 213,522 | -4.06 | -63.04% |
| 6 Months | 3.23 | 8.48 | 2.05 | 5.44 | 129,638 | -0.85 | -26.32% |
| 1 Year | 3.02 | 8.48 | 1.85 | 4.98 | 76,659 | -0.64 | -21.19% |
| 3 Years | 18.00 | 19.90 | 1.45 | 11.62 | 532,664 | -15.62 | -86.78% |
| 5 Years | 33.70 | 39.00 | 1.45 | 15.64 | 474,791 | -31.32 | -92.94% |
CASI Pharmaceuticals Description
| CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world. |
